Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.

about

Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia.

P2860

Q47159895-090EADEA-1029-4FEB-A80B-9BE99B1899FE

P2860

Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.

Item

http://www.wikidata.org/entity/Q38708018

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Long-Term Cardiovascular Risk ...... entified by Cascade Screening.

@en

type

Item

label

Long-Term Cardiovascular Risk ...... entified by Cascade Screening.

@en

prefLabel

Long-Term Cardiovascular Risk ...... entified by Cascade Screening.

@en

P1476

Long-Term Cardiovascular Risk ...... dentified by Cascade Screening

@en

P2093

Henrik Kjærulf Jensen

http://www.w3.org/2001/XMLSchema#string

Kasper Aalbæk Kjærgaard

http://www.w3.org/2001/XMLSchema#string

Morten Smærup Olsen

http://www.w3.org/2001/XMLSchema#string

P2860

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

The Danish National Patient Registry: a review of content, data quality, and research potential

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions

P31

scholarly article

P356

10.1161/JAHA.116.005435

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Morten Schmidt

Morten Krogh Christiansen

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652386

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

5669167

http://www.w3.org/2001/XMLSchema#string

Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.

about

P2860

P2860

Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932